kabutan

SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.(2395) Summary

2395
TSE Prime
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD.
1,553
JPY
-6
(-0.38%)
Mar 13, 3:30 pm JST
9.74
USD
Mar 13, 2:30 am EDT
Result
PTS
outside of trading hours
1,560
Mar 13, 9:00 pm JST
Summary Chart Historical News Financial Result
PER
18.1
PBR
1.22
Yield
3.22%
Margin Trading Ratio
5.83
Stock Price
Mar 13, 2026
Opening Mar 13, 9:00 am
1,520 JPY 9.54 USD
Previous Close Mar 12
1,559 JPY 9.80 USD
High Mar 13, 10:28 am
1,574 JPY 9.89 USD
Low Mar 13, 9:00 am
1,520 JPY 9.54 USD
Volume
118,900
Trading Value
0.19B JPY 1.16M USD
VWAP
1555.84 JPY 9.76 USD
Minimum Trading Value
155,300 JPY 974 USD
Market Cap
0.06T JPY 0.41B USD
Number of Trades
406
Liquidity & Number of Trades
As of Mar 13, 2026
Liquidity
Slightly High
1-Year Average
874
1-Year High May 1, 2025
5,267
Margin Trading
Date Short Interest Long Margin Positions Ratio
Mar 6, 2026 84,500 877,700 10.39
Feb 27, 2026 77,200 851,700 11.03
Feb 20, 2026 69,700 855,900 12.28
Feb 13, 2026 76,700 828,000 10.80
Feb 6, 2026 67,200 859,100 12.78
Company Profile
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. is the domestic leader in preclinical testing services. The company offers services from basic research to contract testing, with a focus on pharmaceutical formulations. It is also involved in regenerative medicine.
Sector
Services
SHIN NIPPON BIOMEDICAL LABORATORIES, LTD. primarily operates in the CRO (Contract Research Organization) business, supporting pharmaceutical development. The company also engages in translational research, leveraging its proprietary nasal drug delivery technology and nurturing basic knowledge and technologies from universities and biotech ventures into viable businesses. Additionally, as part of its Medipolis project (a social benefit creation initiative), the company operates geothermal power generation and accommodation facilities utilizing its property in Ibusuki City, Kagoshima Prefecture.